

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * dopamine transport (GO:0015872) | 6.19159378 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.83444233 |
| 3 | dopamine biosynthetic process (GO:0042416) | 5.80941793 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.94463734 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.76108104 |
| 6 | neuron recognition (GO:0008038) | 4.70686602 |
| 7 | * catecholamine transport (GO:0051937) | 4.69593270 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.63040932 |
| 9 | vocalization behavior (GO:0071625) | 4.62487715 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.59902349 |
| 11 | behavioral response to nicotine (GO:0035095) | 4.59229633 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.40618953 |
| 13 | mating behavior (GO:0007617) | 4.35635209 |
| 14 | neural tube formation (GO:0001841) | 4.34669362 |
| 15 | protein localization to synapse (GO:0035418) | 4.34173873 |
| 16 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.27450010 |
| 17 | regulation of catecholamine metabolic process (GO:0042069) | 4.24892225 |
| 18 | regulation of dopamine metabolic process (GO:0042053) | 4.24892225 |
| 19 | fucose catabolic process (GO:0019317) | 4.22142719 |
| 20 | L-fucose metabolic process (GO:0042354) | 4.22142719 |
| 21 | L-fucose catabolic process (GO:0042355) | 4.22142719 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.20431237 |
| 23 | indolalkylamine metabolic process (GO:0006586) | 4.17700915 |
| 24 | exploration behavior (GO:0035640) | 4.11562474 |
| 25 | response to histamine (GO:0034776) | 4.11027112 |
| 26 | glutamate secretion (GO:0014047) | 4.07883210 |
| 27 | regulation of protein kinase A signaling (GO:0010738) | 4.07155216 |
| 28 | negative regulation of neurotransmitter transport (GO:0051589) | 4.03527791 |
| 29 | prepulse inhibition (GO:0060134) | 3.97396802 |
| 30 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96296971 |
| 31 | behavioral response to cocaine (GO:0048148) | 3.94648789 |
| 32 | opioid receptor signaling pathway (GO:0038003) | 3.93100640 |
| 33 | regulation of vesicle fusion (GO:0031338) | 3.88575126 |
| 34 | piRNA metabolic process (GO:0034587) | 3.86401443 |
| 35 | response to pheromone (GO:0019236) | 3.86250948 |
| 36 | protein K11-linked deubiquitination (GO:0035871) | 3.84356707 |
| 37 | behavioral response to ethanol (GO:0048149) | 3.83484457 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.82986534 |
| 39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.82697305 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81874788 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.75069376 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 3.75069376 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 3.75069376 |
| 44 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.73987673 |
| 45 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.73903468 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.72548610 |
| 47 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.71995966 |
| 48 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.70649181 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.69032017 |
| 50 | synaptic transmission, dopaminergic (GO:0001963) | 3.68345566 |
| 51 | presynaptic membrane assembly (GO:0097105) | 3.66761909 |
| 52 | proline transport (GO:0015824) | 3.66041590 |
| 53 | neurotransmitter transport (GO:0006836) | 3.61622228 |
| 54 | positive regulation of synapse assembly (GO:0051965) | 3.58037059 |
| 55 | ATP synthesis coupled proton transport (GO:0015986) | 3.57994172 |
| 56 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.57994172 |
| 57 | locomotory exploration behavior (GO:0035641) | 3.57845171 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 3.57509058 |
| 59 | neurotransmitter secretion (GO:0007269) | 3.57394291 |
| 60 | behavioral defense response (GO:0002209) | 3.56994246 |
| 61 | behavioral fear response (GO:0001662) | 3.56994246 |
| 62 | photoreceptor cell maintenance (GO:0045494) | 3.56344608 |
| 63 | axonal fasciculation (GO:0007413) | 3.55910388 |
| 64 | kynurenine metabolic process (GO:0070189) | 3.53569444 |
| 65 | righting reflex (GO:0060013) | 3.52083830 |
| 66 | neuronal action potential propagation (GO:0019227) | 3.51934544 |
| 67 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.51569469 |
| 68 | neurotransmitter catabolic process (GO:0042135) | 3.47986558 |
| 69 | respiratory electron transport chain (GO:0022904) | 3.47617980 |
| 70 | regulation of postsynaptic membrane potential (GO:0060078) | 3.46202174 |
| 71 | fear response (GO:0042596) | 3.45238375 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.45078211 |
| 73 | catechol-containing compound biosynthetic process (GO:0009713) | 3.42792779 |
| 74 | catecholamine biosynthetic process (GO:0042423) | 3.42792779 |
| 75 | detection of light stimulus involved in visual perception (GO:0050908) | 3.42548723 |
| 76 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.42548723 |
| 77 | cellular ketone body metabolic process (GO:0046950) | 3.41035999 |
| 78 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.39965143 |
| 79 | electron transport chain (GO:0022900) | 3.39621881 |
| 80 | neuromuscular process controlling posture (GO:0050884) | 3.38450700 |
| 81 | layer formation in cerebral cortex (GO:0021819) | 3.37481365 |
| 82 | tryptophan metabolic process (GO:0006568) | 3.35729875 |
| 83 | synaptic vesicle maturation (GO:0016188) | 3.34843624 |
| 84 | positive regulation of dendritic spine development (GO:0060999) | 3.32927727 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31465068 |
| 86 | multicellular organism reproduction (GO:0032504) | 3.31334667 |
| 87 | regulation of synaptic vesicle transport (GO:1902803) | 3.31221141 |
| 88 | positive regulation of response to oxidative stress (GO:1902884) | 3.29236502 |
| 89 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.29236502 |
| 90 | long-term memory (GO:0007616) | 3.28122149 |
| 91 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.28117849 |
| 92 | retinal cone cell development (GO:0046549) | 3.26670245 |
| 93 | startle response (GO:0001964) | 3.25349444 |
| 94 | epithelial cilium movement (GO:0003351) | 3.25019598 |
| 95 | presynaptic membrane organization (GO:0097090) | 3.23208332 |
| 96 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.22267188 |
| 97 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.21845351 |
| 98 | gamma-aminobutyric acid transport (GO:0015812) | 3.20741418 |
| 99 | response to cocaine (GO:0042220) | 3.19320066 |
| 100 | synaptic vesicle endocytosis (GO:0048488) | 3.18391041 |
| 101 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.17496251 |
| 102 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.17496221 |
| 103 | regulation of memory T cell differentiation (GO:0043380) | 3.16133831 |
| 104 | axoneme assembly (GO:0035082) | 3.15871329 |
| 105 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.14089018 |
| 106 | protein localization to cilium (GO:0061512) | 3.13041334 |
| 107 | regulation of synapse structural plasticity (GO:0051823) | 3.12372144 |
| 108 | synapse assembly (GO:0007416) | 3.12079812 |
| 109 | indole-containing compound metabolic process (GO:0042430) | 3.11774434 |
| 110 | postsynaptic membrane organization (GO:0001941) | 3.11700658 |
| 111 | alkaloid metabolic process (GO:0009820) | 3.10673759 |
| 112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.09704131 |
| 113 | protein prenylation (GO:0018342) | 3.08797997 |
| 114 | prenylation (GO:0097354) | 3.08797997 |
| 115 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.08485261 |
| 116 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.06870973 |
| 117 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05591659 |
| 118 | nonmotile primary cilium assembly (GO:0035058) | 3.05451670 |
| 119 | neuron remodeling (GO:0016322) | 3.04988151 |
| 120 | ketone body metabolic process (GO:1902224) | 3.04975865 |
| 121 | DNA methylation involved in gamete generation (GO:0043046) | 3.04110958 |
| 122 | reflex (GO:0060004) | 3.03071838 |
| 123 | reciprocal DNA recombination (GO:0035825) | 3.02732272 |
| 124 | reciprocal meiotic recombination (GO:0007131) | 3.02732272 |
| 125 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.01195816 |
| 126 | respiratory chain complex IV assembly (GO:0008535) | 3.00092566 |
| 127 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00007111 |
| 128 | neuronal action potential (GO:0019228) | 2.99735643 |
| 129 | regulation of glutamate secretion (GO:0014048) | 2.98868358 |
| 130 | positive regulation of neurotransmitter transport (GO:0051590) | 2.97777998 |
| 131 | replication fork processing (GO:0031297) | 2.97490260 |
| 132 | innervation (GO:0060384) | 2.97185136 |
| 133 | neurotransmitter uptake (GO:0001504) | 2.97034735 |
| 134 | regulation of meiosis I (GO:0060631) | 2.96710572 |
| 135 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95480051 |
| 136 | suckling behavior (GO:0001967) | 2.93277451 |
| 137 | negative regulation of mast cell activation (GO:0033004) | 2.92415039 |
| 138 | platelet dense granule organization (GO:0060155) | 2.92302461 |
| 139 | regulation of dendritic spine development (GO:0060998) | 2.92005202 |
| 140 | neurotransmitter biosynthetic process (GO:0042136) | 2.88518642 |
| 141 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.88352556 |
| 142 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.88251026 |
| 143 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.87413155 |
| 144 | * transmission of nerve impulse (GO:0019226) | 2.87330142 |
| 145 | male meiosis I (GO:0007141) | 2.86909585 |
| 146 | synapsis (GO:0007129) | 2.86391334 |
| 147 | long-term synaptic potentiation (GO:0060291) | 2.84833147 |
| 148 | DNA double-strand break processing (GO:0000729) | 2.83263949 |
| 149 | protein polyglutamylation (GO:0018095) | 2.81653931 |
| 150 | regulation of acrosome reaction (GO:0060046) | 2.81604985 |
| 151 | regulation of hippo signaling (GO:0035330) | 2.81451868 |
| 152 | cilium morphogenesis (GO:0060271) | 2.80525775 |
| 153 | cytochrome complex assembly (GO:0017004) | 2.80190534 |
| 154 | mannosylation (GO:0097502) | 2.78436405 |
| 155 | cilium movement (GO:0003341) | 2.77050290 |
| 156 | establishment of protein localization to Golgi (GO:0072600) | 2.76988403 |
| 157 | sulfation (GO:0051923) | 2.76423367 |
| 158 | cellular biogenic amine catabolic process (GO:0042402) | 2.75929676 |
| 159 | amine catabolic process (GO:0009310) | 2.75929676 |
| 160 | intraciliary transport (GO:0042073) | 2.74346409 |
| 161 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.73869595 |
| 162 | double-strand break repair via homologous recombination (GO:0000724) | 2.73508944 |
| 163 | regulation of cilium movement (GO:0003352) | 2.73280009 |
| 164 | recombinational repair (GO:0000725) | 2.73231378 |
| 165 | cilium organization (GO:0044782) | 2.72248973 |
| 166 | sperm motility (GO:0030317) | 2.72071855 |
| 167 | adaptation of signaling pathway (GO:0023058) | 2.70347243 |
| 168 | cilium assembly (GO:0042384) | 2.65552628 |
| 169 | nucleobase catabolic process (GO:0046113) | 2.62546005 |
| 170 | regulation of glucokinase activity (GO:0033131) | 2.61772068 |
| 171 | regulation of hexokinase activity (GO:1903299) | 2.61772068 |
| 172 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.61594634 |
| 173 | regulation of collateral sprouting (GO:0048670) | 2.57628331 |
| 174 | cornea development in camera-type eye (GO:0061303) | 2.57318389 |
| 175 | oxidative demethylation (GO:0070989) | 2.56740065 |
| 176 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.56029786 |
| 177 | auditory receptor cell stereocilium organization (GO:0060088) | 2.54950105 |
| 178 | embryonic epithelial tube formation (GO:0001838) | 2.53870706 |
| 179 | inner ear receptor stereocilium organization (GO:0060122) | 2.53358442 |
| 180 | thyroid hormone metabolic process (GO:0042403) | 2.53071458 |
| 181 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.53061677 |
| 182 | DNA deamination (GO:0045006) | 2.52633651 |
| 183 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.52360868 |
| 184 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.52360868 |
| 185 | primary amino compound metabolic process (GO:1901160) | 2.50681229 |
| 186 | C4-dicarboxylate transport (GO:0015740) | 2.50527670 |
| 187 | serotonin metabolic process (GO:0042428) | 2.50206948 |
| 188 | DNA integration (GO:0015074) | 2.48823696 |
| 189 | spinal cord motor neuron differentiation (GO:0021522) | 2.44931304 |
| 190 | central nervous system neuron axonogenesis (GO:0021955) | 2.43157595 |
| 191 | protein complex biogenesis (GO:0070271) | 2.42498051 |
| 192 | positive regulation of meiosis (GO:0045836) | 2.42423615 |
| 193 | adenosine metabolic process (GO:0046085) | 2.41944368 |
| 194 | regulation of action potential (GO:0098900) | 2.41609935 |
| 195 | synaptic transmission, cholinergic (GO:0007271) | 2.40831583 |
| 196 | photoreceptor cell development (GO:0042461) | 2.40809371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.51147811 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.73751714 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.23161020 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.21493879 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21487802 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09515392 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.82076118 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62825453 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62825453 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.58757407 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57595986 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52330133 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48351877 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.46766149 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46493947 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.43005691 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38985110 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36933179 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.30768738 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.30105835 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.22151365 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21789425 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.20921925 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15863709 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15164007 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.06974450 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01371673 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.95183420 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93280334 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93106729 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.92163059 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85638543 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82018023 |
| 34 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.80791996 |
| 35 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.78645451 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.78645451 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75214539 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.71476502 |
| 39 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.68641358 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68529683 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.68372327 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64691938 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63999313 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61831857 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.59112094 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58105217 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57892673 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57766502 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.56427772 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53540180 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51366421 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.50794560 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49920057 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.49644160 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48856388 |
| 56 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.48620494 |
| 57 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.47002675 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46633467 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45301239 |
| 60 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44438745 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44257937 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43088751 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43025129 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41100868 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40798107 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40798107 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40019363 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39637512 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39413728 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37960291 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37385481 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.37149367 |
| 73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36394937 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36394937 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.36197023 |
| 76 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35226838 |
| 77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30197296 |
| 78 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.29784710 |
| 79 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29442359 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29079153 |
| 81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27314629 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25214833 |
| 83 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24759363 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24524643 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23009674 |
| 86 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.22954318 |
| 87 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.22954318 |
| 88 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22852775 |
| 89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22099303 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21433058 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20725840 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17122204 |
| 93 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16121369 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15389135 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14872483 |
| 96 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14442249 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14210218 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13789469 |
| 99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13722137 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12878771 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12128854 |
| 102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11753434 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11563490 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11264762 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10738581 |
| 106 | JUN_21703547_ChIP-Seq_K562_Human | 1.10175299 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09497507 |
| 108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09448264 |
| 109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08456497 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07666690 |
| 111 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07264444 |
| 112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06972022 |
| 113 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.06476230 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05252315 |
| 115 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05055615 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04802571 |
| 117 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04477544 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02974364 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02662393 |
| 120 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.02039251 |
| 121 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01133164 |
| 122 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.99372634 |
| 123 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98556825 |
| 124 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98010497 |
| 125 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97602845 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97454077 |
| 127 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96673277 |
| 128 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96329011 |
| 129 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95672277 |
| 130 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95640926 |
| 131 | AR_19668381_ChIP-Seq_PC3_Human | 0.95429523 |
| 132 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95079009 |
| 133 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93418803 |
| 134 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91260042 |
| 135 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91215776 |
| 136 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91122583 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89059686 |
| 138 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89014542 |
| 139 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88043855 |
| 140 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87953973 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86905821 |
| 142 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.86743008 |
| 143 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84869675 |
| 144 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83727799 |
| 145 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83404248 |
| 146 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83370272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 7.15473718 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.55159444 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.70523022 |
| 4 | MP0003195_calcinosis | 3.65052298 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.29282212 |
| 6 | MP0009046_muscle_twitch | 3.29068852 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.28150057 |
| 8 | MP0006276_abnormal_autonomic_nervous | 3.23026388 |
| 9 | MP0008877_abnormal_DNA_methylation | 3.06291976 |
| 10 | MP0002064_seizures | 3.04365286 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.96296996 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.92981272 |
| 13 | MP0001440_abnormal_grooming_behavior | 2.86061983 |
| 14 | MP0001905_abnormal_dopamine_level | 2.83564439 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.67397829 |
| 16 | MP0002736_abnormal_nociception_after | 2.65017957 |
| 17 | * MP0001529_abnormal_vocalization | 2.64798425 |
| 18 | MP0004270_analgesia | 2.52298008 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.46538932 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.46445679 |
| 21 | MP0002272_abnormal_nervous_system | 2.35806469 |
| 22 | MP0001486_abnormal_startle_reflex | 2.34133295 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.34014476 |
| 24 | MP0003122_maternal_imprinting | 2.22068148 |
| 25 | MP0004147_increased_porphyrin_level | 2.10846149 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 2.10675709 |
| 27 | MP0002822_catalepsy | 2.10093443 |
| 28 | MP0004142_abnormal_muscle_tone | 2.05375503 |
| 29 | * MP0004924_abnormal_behavior | 1.98468378 |
| 30 | * MP0005386_behavior/neurological_phenoty | 1.98468378 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.98019543 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.93055312 |
| 33 | MP0003329_amyloid_beta_deposits | 1.86586528 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.86550731 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.83636670 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.81243024 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.79869519 |
| 38 | MP0001970_abnormal_pain_threshold | 1.78330159 |
| 39 | MP0002184_abnormal_innervation | 1.72519129 |
| 40 | MP0002733_abnormal_thermal_nociception | 1.72121408 |
| 41 | MP0000427_abnormal_hair_cycle | 1.69738493 |
| 42 | MP0000778_abnormal_nervous_system | 1.67451735 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.64067595 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.60564477 |
| 45 | MP0003252_abnormal_bile_duct | 1.59365699 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.56645610 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.55129812 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.48527884 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.46595796 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.44150104 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.43313041 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.42122981 |
| 53 | MP0003136_yellow_coat_color | 1.40968979 |
| 54 | MP0003646_muscle_fatigue | 1.39292034 |
| 55 | MP0003718_maternal_effect | 1.37454620 |
| 56 | MP0002938_white_spotting | 1.36423090 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.35458612 |
| 58 | MP0002066_abnormal_motor_capabilities/c | 1.34184295 |
| 59 | MP0002882_abnormal_neuron_morphology | 1.26470283 |
| 60 | MP0008057_abnormal_DNA_replication | 1.24012729 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.22736755 |
| 62 | MP0008872_abnormal_physiological_respon | 1.22559557 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.21844054 |
| 64 | MP0005389_reproductive_system_phenotype | 1.20750042 |
| 65 | MP0004133_heterotaxia | 1.20488558 |
| 66 | MP0008058_abnormal_DNA_repair | 1.20464597 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.20228486 |
| 68 | MP0000955_abnormal_spinal_cord | 1.20124042 |
| 69 | MP0005535_abnormal_body_temperature | 1.19541540 |
| 70 | MP0001984_abnormal_olfaction | 1.18480330 |
| 71 | MP0003698_abnormal_male_reproductive | 1.18362228 |
| 72 | MP0002928_abnormal_bile_duct | 1.17101862 |
| 73 | MP0001188_hyperpigmentation | 1.16985147 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.16741393 |
| 75 | MP0000751_myopathy | 1.15036973 |
| 76 | MP0002160_abnormal_reproductive_system | 1.13242665 |
| 77 | MP0004742_abnormal_vestibular_system | 1.12430062 |
| 78 | MP0002751_abnormal_autonomic_nervous | 1.12281136 |
| 79 | MP0001929_abnormal_gametogenesis | 1.11066811 |
| 80 | MP0008569_lethality_at_weaning | 1.11000993 |
| 81 | MP0005409_darkened_coat_color | 1.09586892 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 1.07450810 |
| 83 | MP0004811_abnormal_neuron_physiology | 1.06873899 |
| 84 | MP0004043_abnormal_pH_regulation | 1.06742107 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 1.05480602 |
| 86 | MP0000647_abnormal_sebaceous_gland | 1.04985865 |
| 87 | MP0003011_delayed_dark_adaptation | 1.04126255 |
| 88 | MP0005551_abnormal_eye_electrophysiolog | 1.04006801 |
| 89 | MP0000383_abnormal_hair_follicle | 1.03802521 |
| 90 | MP0009697_abnormal_copulation | 1.03453014 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.01313153 |
| 92 | MP0010386_abnormal_urinary_bladder | 1.00226950 |
| 93 | MP0002229_neurodegeneration | 0.97912229 |
| 94 | MP0003690_abnormal_glial_cell | 0.97836324 |
| 95 | MP0002163_abnormal_gland_morphology | 0.96973182 |
| 96 | MP0005410_abnormal_fertilization | 0.96456907 |
| 97 | MP0000604_amyloidosis | 0.96006601 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.95702770 |
| 99 | MP0000920_abnormal_myelination | 0.94353211 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.94302347 |
| 101 | MP0002152_abnormal_brain_morphology | 0.93164422 |
| 102 | MP0008874_decreased_physiological_sensi | 0.90986611 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.90084338 |
| 104 | MP0000538_abnormal_urinary_bladder | 0.89249355 |
| 105 | MP0002210_abnormal_sex_determination | 0.89052844 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.87904299 |
| 107 | MP0002090_abnormal_vision | 0.87352534 |
| 108 | * MP0002069_abnormal_eating/drinking_beha | 0.86997676 |
| 109 | MP0000653_abnormal_sex_gland | 0.86846274 |
| 110 | MP0004885_abnormal_endolymph | 0.86800647 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.86678547 |
| 112 | * MP0001664_abnormal_digestion | 0.86319911 |
| 113 | MP0006054_spinal_hemorrhage | 0.85970588 |
| 114 | MP0003631_nervous_system_phenotype | 0.83943312 |
| 115 | MP0005085_abnormal_gallbladder_physiolo | 0.83365827 |
| 116 | MP0004484_altered_response_of | 0.82631626 |
| 117 | MP0003633_abnormal_nervous_system | 0.81810930 |
| 118 | MP0005195_abnormal_posterior_eye | 0.81651876 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.81618752 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.80416471 |
| 121 | MP0003634_abnormal_glial_cell | 0.78884646 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.78284516 |
| 123 | MP0003632_abnormal_nervous_system | 0.77941645 |
| 124 | MP0004858_abnormal_nervous_system | 0.77916693 |
| 125 | MP0003121_genomic_imprinting | 0.77799307 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.77424144 |
| 127 | MP0001145_abnormal_male_reproductive | 0.77353006 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.77148932 |
| 129 | MP0001919_abnormal_reproductive_system | 0.76494416 |
| 130 | MP0008995_early_reproductive_senescence | 0.75923295 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.75127174 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.73972422 |
| 133 | MP0005187_abnormal_penis_morphology | 0.73842552 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.72477554 |
| 135 | MP0010678_abnormal_skin_adnexa | 0.72184865 |
| 136 | MP0004085_abnormal_heartbeat | 0.72184299 |
| 137 | MP0005379_endocrine/exocrine_gland_phen | 0.68237143 |
| 138 | MP0003283_abnormal_digestive_organ | 0.67273823 |
| 139 | MP0002102_abnormal_ear_morphology | 0.66197627 |
| 140 | MP0005394_taste/olfaction_phenotype | 0.65801090 |
| 141 | MP0005499_abnormal_olfactory_system | 0.65801090 |
| 142 | MP0000747_muscle_weakness | 0.64949220 |
| 143 | MP0005253_abnormal_eye_physiology | 0.64209664 |
| 144 | MP0003123_paternal_imprinting | 0.64016980 |
| 145 | MP0002139_abnormal_hepatobiliary_system | 0.62932628 |
| 146 | MP0000013_abnormal_adipose_tissue | 0.61772734 |
| 147 | MP0000026_abnormal_inner_ear | 0.59799171 |
| 148 | MP0010234_abnormal_vibrissa_follicle | 0.59687986 |
| 149 | MP0003787_abnormal_imprinting | 0.59612934 |
| 150 | MP0001943_abnormal_respiration | 0.59459066 |
| 151 | MP0003879_abnormal_hair_cell | 0.56491875 |
| 152 | MP0001299_abnormal_eye_distance/ | 0.53683237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.89680319 |
| 2 | Visual hallucinations (HP:0002367) | 6.59727967 |
| 3 | Limb dystonia (HP:0002451) | 5.44358390 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 5.25739231 |
| 5 | Focal seizures (HP:0007359) | 4.79275297 |
| 6 | Myokymia (HP:0002411) | 4.70878332 |
| 7 | Neurofibrillary tangles (HP:0002185) | 4.60847035 |
| 8 | Atonic seizures (HP:0010819) | 4.40250295 |
| 9 | Absence seizures (HP:0002121) | 4.33728250 |
| 10 | Pancreatic cysts (HP:0001737) | 4.32580495 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.95102242 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.90570156 |
| 13 | True hermaphroditism (HP:0010459) | 3.90475500 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.86795854 |
| 15 | Dialeptic seizures (HP:0011146) | 3.83270214 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.80982266 |
| 17 | Medial flaring of the eyebrow (HP:0010747) | 3.62763097 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.53798290 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.41586796 |
| 20 | Febrile seizures (HP:0002373) | 3.37997705 |
| 21 | Nephronophthisis (HP:0000090) | 3.33309365 |
| 22 | Attenuation of retinal blood vessels (HP:0007843) | 3.31984067 |
| 23 | Progressive macrocephaly (HP:0004481) | 3.28021172 |
| 24 | Type II lissencephaly (HP:0007260) | 3.27441063 |
| 25 | Pheochromocytoma (HP:0002666) | 3.22671273 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.21301562 |
| 27 | Epileptic encephalopathy (HP:0200134) | 3.18640324 |
| 28 | Anxiety (HP:0000739) | 3.15258282 |
| 29 | Mitochondrial inheritance (HP:0001427) | 3.10192088 |
| 30 | Truncal ataxia (HP:0002078) | 3.05015871 |
| 31 | Chronic hepatic failure (HP:0100626) | 3.04525206 |
| 32 | Acute encephalopathy (HP:0006846) | 3.00818147 |
| 33 | Broad-based gait (HP:0002136) | 2.94367867 |
| 34 | Hyperventilation (HP:0002883) | 2.93219837 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.93201250 |
| 36 | Delusions (HP:0000746) | 2.91067520 |
| 37 | Abolished electroretinogram (ERG) (HP:0000550) | 2.85549940 |
| 38 | Neuroendocrine neoplasm (HP:0100634) | 2.84661339 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.82673404 |
| 40 | Intestinal atresia (HP:0011100) | 2.79534869 |
| 41 | Abnormality of the renal cortex (HP:0011035) | 2.79434896 |
| 42 | Drooling (HP:0002307) | 2.76828572 |
| 43 | Excessive salivation (HP:0003781) | 2.76828572 |
| 44 | Polyphagia (HP:0002591) | 2.73270831 |
| 45 | Cystic liver disease (HP:0006706) | 2.71848431 |
| 46 | Cerebral hemorrhage (HP:0001342) | 2.70751664 |
| 47 | Infantile muscular hypotonia (HP:0008947) | 2.70389473 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.69366086 |
| 49 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.67819023 |
| 50 | Cerebellar dysplasia (HP:0007033) | 2.67325633 |
| 51 | Psychosis (HP:0000709) | 2.66659665 |
| 52 | Absent speech (HP:0001344) | 2.63283087 |
| 53 | Abnormality of the corticospinal tract (HP:0002492) | 2.61783899 |
| 54 | Failure to thrive in infancy (HP:0001531) | 2.56922101 |
| 55 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.56228491 |
| 56 | Dysmetria (HP:0001310) | 2.55205234 |
| 57 | Facial shape deformation (HP:0011334) | 2.54626223 |
| 58 | Potter facies (HP:0002009) | 2.54626223 |
| 59 | Insidious onset (HP:0003587) | 2.53997218 |
| 60 | Termporal pattern (HP:0011008) | 2.53997218 |
| 61 | Increased CSF lactate (HP:0002490) | 2.52731605 |
| 62 | Abnormality of binocular vision (HP:0011514) | 2.51259823 |
| 63 | Diplopia (HP:0000651) | 2.51259823 |
| 64 | Hypoventilation (HP:0002791) | 2.50665615 |
| 65 | Pendular nystagmus (HP:0012043) | 2.50372707 |
| 66 | Thyroid-stimulating hormone excess (HP:0002925) | 2.50304813 |
| 67 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.49369596 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47315487 |
| 69 | Agitation (HP:0000713) | 2.47169575 |
| 70 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.46748152 |
| 71 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.46748152 |
| 72 | Genetic anticipation (HP:0003743) | 2.44853806 |
| 73 | Inability to walk (HP:0002540) | 2.42764798 |
| 74 | Genital tract atresia (HP:0001827) | 2.42304003 |
| 75 | Action tremor (HP:0002345) | 2.40856806 |
| 76 | Depression (HP:0000716) | 2.38078553 |
| 77 | Bradykinesia (HP:0002067) | 2.37661937 |
| 78 | Abnormal eating behavior (HP:0100738) | 2.37140008 |
| 79 | Stomach cancer (HP:0012126) | 2.36291910 |
| 80 | Decreased central vision (HP:0007663) | 2.32863278 |
| 81 | Progressive inability to walk (HP:0002505) | 2.32164996 |
| 82 | Hypokinesia (HP:0002375) | 2.32039051 |
| 83 | Rapidly progressive (HP:0003678) | 2.31806959 |
| 84 | Tubular atrophy (HP:0000092) | 2.31307992 |
| 85 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.28573337 |
| 86 | Vaginal atresia (HP:0000148) | 2.27146745 |
| 87 | Sensory axonal neuropathy (HP:0003390) | 2.26536469 |
| 88 | Epileptiform EEG discharges (HP:0011182) | 2.25956854 |
| 89 | Optic disc pallor (HP:0000543) | 2.25260107 |
| 90 | Abnormality of macular pigmentation (HP:0008002) | 2.24875093 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 2.24464699 |
| 92 | Bile duct proliferation (HP:0001408) | 2.24464699 |
| 93 | Generalized myoclonic seizures (HP:0002123) | 2.21948844 |
| 94 | Sclerocornea (HP:0000647) | 2.21781746 |
| 95 | Mutism (HP:0002300) | 2.20712309 |
| 96 | Poor suck (HP:0002033) | 2.19406434 |
| 97 | Retinal dysplasia (HP:0007973) | 2.18657866 |
| 98 | Abnormality of alanine metabolism (HP:0010916) | 2.18618432 |
| 99 | Hyperalaninemia (HP:0003348) | 2.18618432 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.18618432 |
| 101 | Lipid accumulation in hepatocytes (HP:0006561) | 2.17648957 |
| 102 | Delayed gross motor development (HP:0002194) | 2.16955758 |
| 103 | Cerebral edema (HP:0002181) | 2.16831716 |
| 104 | Hemiparesis (HP:0001269) | 2.16490675 |
| 105 | Diminished movement (HP:0002374) | 2.16442739 |
| 106 | Postural tremor (HP:0002174) | 2.16186247 |
| 107 | Hepatocellular necrosis (HP:0001404) | 2.14798154 |
| 108 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13757240 |
| 109 | Keratoconus (HP:0000563) | 2.13393168 |
| 110 | Increased corneal curvature (HP:0100692) | 2.13393168 |
| 111 | Lissencephaly (HP:0001339) | 2.13109698 |
| 112 | Abnormal pupillary function (HP:0007686) | 2.12579424 |
| 113 | Amblyopia (HP:0000646) | 2.11012017 |
| 114 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.10788060 |
| 115 | Renal Fanconi syndrome (HP:0001994) | 2.10209218 |
| 116 | Rigidity (HP:0002063) | 2.08140127 |
| 117 | Poor coordination (HP:0002370) | 2.07494616 |
| 118 | Poor eye contact (HP:0000817) | 2.07459547 |
| 119 | Chronic otitis media (HP:0000389) | 2.06821493 |
| 120 | Congenital hepatic fibrosis (HP:0002612) | 2.06481343 |
| 121 | Scanning speech (HP:0002168) | 2.06305694 |
| 122 | Gait imbalance (HP:0002141) | 2.05447294 |
| 123 | Abnormality of the parathyroid morphology (HP:0011766) | 2.04545325 |
| 124 | Dysdiadochokinesis (HP:0002075) | 2.04002282 |
| 125 | Esotropia (HP:0000565) | 2.03676295 |
| 126 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.03588069 |
| 127 | Congenital sensorineural hearing impairment (HP:0008527) | 2.02786467 |
| 128 | Testicular neoplasm (HP:0010788) | 2.02417138 |
| 129 | Furrowed tongue (HP:0000221) | 2.02322987 |
| 130 | Leukodystrophy (HP:0002415) | 2.01643494 |
| 131 | Male pseudohermaphroditism (HP:0000037) | 1.99981147 |
| 132 | Hypothermia (HP:0002045) | 1.97947723 |
| 133 | Clumsiness (HP:0002312) | 1.96874256 |
| 134 | Postaxial foot polydactyly (HP:0001830) | 1.96129459 |
| 135 | Large for gestational age (HP:0001520) | 1.95807482 |
| 136 | Molar tooth sign on MRI (HP:0002419) | 1.95728328 |
| 137 | Abnormality of midbrain morphology (HP:0002418) | 1.95728328 |
| 138 | Occipital encephalocele (HP:0002085) | 1.95305623 |
| 139 | Ketoacidosis (HP:0001993) | 1.94476349 |
| 140 | Hypsarrhythmia (HP:0002521) | 1.94100954 |
| 141 | Retinitis pigmentosa (HP:0000510) | 1.93807248 |
| 142 | Anencephaly (HP:0002323) | 1.93716449 |
| 143 | Abnormal drinking behavior (HP:0030082) | 1.93426568 |
| 144 | Polydipsia (HP:0001959) | 1.93426568 |
| 145 | Widely spaced teeth (HP:0000687) | 1.92605050 |
| 146 | Astigmatism (HP:0000483) | 1.91402247 |
| 147 | Renal cortical cysts (HP:0000803) | 1.91250252 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 1.90849848 |
| 149 | Exotropia (HP:0000577) | 1.90499661 |
| 150 | Restlessness (HP:0000711) | 1.89896782 |
| 151 | Disproportionate short-trunk short stature (HP:0003521) | 1.89787768 |
| 152 | Optic nerve hypoplasia (HP:0000609) | 1.89759567 |
| 153 | X-linked dominant inheritance (HP:0001423) | 1.89474205 |
| 154 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.88989971 |
| 155 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88957290 |
| 156 | Blue irides (HP:0000635) | 1.88725489 |
| 157 | Postaxial hand polydactyly (HP:0001162) | 1.87634596 |
| 158 | Impaired social interactions (HP:0000735) | 1.86411256 |
| 159 | Abnormal social behavior (HP:0012433) | 1.86411256 |
| 160 | Myoclonus (HP:0001336) | 1.86087268 |
| 161 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.84425661 |
| 162 | Abnormal ciliary motility (HP:0012262) | 1.84321312 |
| 163 | CNS hypomyelination (HP:0003429) | 1.83723676 |
| 164 | Amelogenesis imperfecta (HP:0000705) | 1.83562181 |
| 165 | Abnormality of the labia minora (HP:0012880) | 1.83544791 |
| 166 | Postural instability (HP:0002172) | 1.83123382 |
| 167 | Thyroiditis (HP:0100646) | 1.79326092 |
| 168 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.79178289 |
| 169 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78976282 |
| 170 | Absent/shortened dynein arms (HP:0200106) | 1.78976282 |
| 171 | Abnormality of the pons (HP:0007361) | 1.77918662 |
| 172 | Protruding tongue (HP:0010808) | 1.77680053 |
| 173 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.74035249 |
| 174 | Constricted visual fields (HP:0001133) | 1.73669568 |
| 175 | Hypoplasia of the pons (HP:0012110) | 1.73348553 |
| 176 | Chorioretinal atrophy (HP:0000533) | 1.71907230 |
| 177 | Concave nail (HP:0001598) | 1.71314397 |
| 178 | Polyuria (HP:0000103) | 1.70250284 |
| 179 | 3-Methylglutaconic aciduria (HP:0003535) | 1.70056146 |
| 180 | Preaxial hand polydactyly (HP:0001177) | 1.68437832 |
| 181 | Volvulus (HP:0002580) | 1.67162035 |
| 182 | Severe muscular hypotonia (HP:0006829) | 1.67047626 |
| 183 | Fair hair (HP:0002286) | 1.65772095 |
| 184 | Severe visual impairment (HP:0001141) | 1.65671510 |
| 185 | Tubulointerstitial nephritis (HP:0001970) | 1.65547180 |
| 186 | Oculomotor apraxia (HP:0000657) | 1.64863367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.10633465 |
| 2 | MAP3K12 | 3.64120394 |
| 3 | NTRK3 | 3.61696026 |
| 4 | PNCK | 3.55709329 |
| 5 | EPHA4 | 2.94602620 |
| 6 | MAP4K2 | 2.91298177 |
| 7 | MAP3K9 | 2.88016323 |
| 8 | WNK3 | 2.69838867 |
| 9 | MARK1 | 2.55444785 |
| 10 | MAP3K4 | 2.51382534 |
| 11 | MINK1 | 2.46624165 |
| 12 | INSRR | 2.45721917 |
| 13 | NUAK1 | 2.32096065 |
| 14 | TRIM28 | 2.31990194 |
| 15 | PLK2 | 2.29149147 |
| 16 | TAOK3 | 2.27524061 |
| 17 | GRK5 | 2.26709489 |
| 18 | ACVR1B | 2.23245026 |
| 19 | PINK1 | 2.13099223 |
| 20 | CASK | 2.11060442 |
| 21 | MAP2K4 | 2.04600270 |
| 22 | GRK7 | 1.97439321 |
| 23 | FGR | 1.95670626 |
| 24 | NTRK1 | 1.89812038 |
| 25 | FES | 1.88156439 |
| 26 | CSNK1G3 | 1.82184556 |
| 27 | MAP2K7 | 1.81833434 |
| 28 | GRK1 | 1.81238751 |
| 29 | PTK2B | 1.78146281 |
| 30 | ARAF | 1.75508926 |
| 31 | MAPKAPK5 | 1.73496109 |
| 32 | NTRK2 | 1.71583490 |
| 33 | CSNK1G2 | 1.71149746 |
| 34 | RIPK4 | 1.69706638 |
| 35 | SIK2 | 1.68550697 |
| 36 | GRK6 | 1.66710615 |
| 37 | CAMK2A | 1.57767551 |
| 38 | ZAK | 1.55908688 |
| 39 | KSR2 | 1.53794621 |
| 40 | TLK1 | 1.49342204 |
| 41 | MAP3K13 | 1.42231664 |
| 42 | CAMK2B | 1.35578757 |
| 43 | CDK5 | 1.35449214 |
| 44 | LATS2 | 1.35273641 |
| 45 | TNK2 | 1.33115146 |
| 46 | NME1 | 1.32669428 |
| 47 | ADRBK2 | 1.30895709 |
| 48 | STK38L | 1.29376918 |
| 49 | TNIK | 1.26682054 |
| 50 | KSR1 | 1.25088218 |
| 51 | STK39 | 1.22931883 |
| 52 | CSNK1G1 | 1.19550658 |
| 53 | PAK3 | 1.13718874 |
| 54 | BCR | 1.13526275 |
| 55 | CAMK2D | 1.12661586 |
| 56 | MST4 | 1.11466297 |
| 57 | MKNK2 | 1.10953760 |
| 58 | TXK | 1.10555975 |
| 59 | CAMKK2 | 1.10106507 |
| 60 | MAPK13 | 1.09868712 |
| 61 | RET | 1.08961754 |
| 62 | OXSR1 | 1.08088098 |
| 63 | PRKCG | 1.05267299 |
| 64 | CDK19 | 1.04610403 |
| 65 | PAK6 | 1.02803298 |
| 66 | DAPK2 | 1.01300846 |
| 67 | EIF2AK3 | 0.98263249 |
| 68 | DAPK1 | 0.98252587 |
| 69 | FER | 0.97152875 |
| 70 | CAMKK1 | 0.91090534 |
| 71 | ERBB3 | 0.89854336 |
| 72 | UHMK1 | 0.89031937 |
| 73 | WNK4 | 0.88157800 |
| 74 | ADRBK1 | 0.87978893 |
| 75 | DYRK1A | 0.86608114 |
| 76 | CAMK1G | 0.85728701 |
| 77 | BRSK2 | 0.84733376 |
| 78 | LATS1 | 0.78597068 |
| 79 | CDK14 | 0.78215744 |
| 80 | BMPR2 | 0.77200649 |
| 81 | CAMK2G | 0.76647316 |
| 82 | TSSK6 | 0.76586358 |
| 83 | FGFR2 | 0.76234849 |
| 84 | STK3 | 0.72551783 |
| 85 | CDK18 | 0.72227541 |
| 86 | PIK3CG | 0.71607696 |
| 87 | MAP3K2 | 0.71472009 |
| 88 | CDK15 | 0.71405523 |
| 89 | TGFBR1 | 0.69124685 |
| 90 | TEC | 0.68405179 |
| 91 | ROCK2 | 0.68198475 |
| 92 | PIK3CA | 0.67474285 |
| 93 | PLK4 | 0.67375109 |
| 94 | PRKCE | 0.66502022 |
| 95 | DYRK2 | 0.60823954 |
| 96 | CDK11A | 0.58473046 |
| 97 | IKBKB | 0.58363997 |
| 98 | IRAK1 | 0.58230338 |
| 99 | VRK1 | 0.57872571 |
| 100 | RAF1 | 0.57260006 |
| 101 | PHKG1 | 0.56972747 |
| 102 | PHKG2 | 0.56972747 |
| 103 | MOS | 0.56888632 |
| 104 | FYN | 0.54638271 |
| 105 | MKNK1 | 0.54511149 |
| 106 | STK11 | 0.53962441 |
| 107 | SGK1 | 0.52606720 |
| 108 | PBK | 0.51216308 |
| 109 | PLK3 | 0.50678235 |
| 110 | STK38 | 0.50607208 |
| 111 | AKT3 | 0.50465538 |
| 112 | EPHB2 | 0.49421520 |
| 113 | CSNK1A1L | 0.47160282 |
| 114 | MYLK | 0.46922513 |
| 115 | PRKACA | 0.46063790 |
| 116 | CHUK | 0.45754417 |
| 117 | CAMK1 | 0.44746826 |
| 118 | NLK | 0.43603557 |
| 119 | MARK3 | 0.43544395 |
| 120 | PKN1 | 0.42763546 |
| 121 | MAP3K7 | 0.42369869 |
| 122 | PRKAA2 | 0.42230493 |
| 123 | CSNK1D | 0.41975037 |
| 124 | DYRK3 | 0.41013791 |
| 125 | CSNK1E | 0.40218771 |
| 126 | NEK6 | 0.39576727 |
| 127 | PRKCQ | 0.37915242 |
| 128 | MARK2 | 0.37836886 |
| 129 | PRPF4B | 0.36735317 |
| 130 | PRKCZ | 0.35964710 |
| 131 | BMPR1B | 0.35200628 |
| 132 | MAP2K1 | 0.34203794 |
| 133 | PRKG1 | 0.34040259 |
| 134 | PRKCA | 0.33506946 |
| 135 | SGK2 | 0.33394236 |
| 136 | MUSK | 0.33137329 |
| 137 | PRKCH | 0.32783418 |
| 138 | SIK3 | 0.32039380 |
| 139 | PRKCB | 0.31314664 |
| 140 | MAPK10 | 0.31072019 |
| 141 | MAPK15 | 0.30291956 |
| 142 | BRD4 | 0.30283929 |
| 143 | PTK2 | 0.29962560 |
| 144 | PRKAA1 | 0.29704546 |
| 145 | STK16 | 0.29291562 |
| 146 | FLT3 | 0.29251702 |
| 147 | CSNK1A1 | 0.28168634 |
| 148 | ABL1 | 0.28061689 |
| 149 | SYK | 0.27422784 |
| 150 | OBSCN | 0.27109148 |
| 151 | SRC | 0.26786219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.62101045 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.46155032 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.09214955 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.95899257 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.79439922 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76038910 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.61999685 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.60925707 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.59973681 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.51025286 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.50960127 |
| 12 | Cocaine addiction_Homo sapiens_hsa05030 | 2.50483687 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.31790623 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.28118993 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 2.27774715 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.26913485 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.22580004 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21028110 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 2.17951332 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.09707682 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 2.05352142 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.01801019 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 2.01384199 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98018455 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.93704105 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.90661549 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.89950345 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.81835849 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.79154918 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.77522991 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76940182 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74642674 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.74568821 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.74350838 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.72167009 |
| 36 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.70895651 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.65232510 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61493389 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.57176178 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55131044 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53831402 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.45480422 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45264649 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44811408 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43448935 |
| 46 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42702137 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42218904 |
| 48 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.38499283 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38451266 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37565747 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.31578804 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30683906 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.27419324 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26370699 |
| 55 | Protein export_Homo sapiens_hsa03060 | 1.25909328 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18254176 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16640260 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15915712 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 1.14792868 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14412453 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 1.13991483 |
| 62 | RNA polymerase_Homo sapiens_hsa03020 | 1.10129836 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09451160 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08301819 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06239024 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 1.03898610 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.98615793 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98290168 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94058231 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89526812 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89249897 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88389531 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85861675 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83918675 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82679054 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81883536 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80000035 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79699946 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.78467764 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76417040 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75678598 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75347839 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71491713 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71232346 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71167560 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68905679 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.68606588 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67778574 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65852284 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65776530 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64278507 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63546268 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62165898 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.59811037 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59180615 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59174866 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57195852 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56261829 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55743021 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.55613862 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55517495 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51523929 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51446288 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48919657 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.47439960 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47347055 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46562730 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45979504 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44366402 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44304645 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44287303 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42653117 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39441596 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39094752 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38420969 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38417519 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37915577 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.37749431 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37711680 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37572525 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37106287 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.36525296 |
| 123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36509249 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36181170 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36003821 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34169434 |
| 127 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32418562 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32160067 |
| 129 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.31803506 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31344085 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29899882 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29520844 |
| 133 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.29155571 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29107074 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.28996956 |
| 136 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28158113 |
| 137 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27707042 |
| 138 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27640542 |
| 139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26370892 |
| 140 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.25039441 |
| 141 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23395113 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23297280 |
| 143 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22720443 |
| 144 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.22491886 |
| 145 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22431762 |
| 146 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.21708188 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20663134 |
| 148 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20127953 |
| 149 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17419906 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16963373 |
| 151 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14375186 |
| 152 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14126301 |
| 153 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14094893 |
| 154 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13227257 |
| 155 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.12900232 |

